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Background: Apocrine acrosyringeal keratosis is a rare skin lesion showing a unique benign keratotic lesion
associated with syringocystoadenoma papilliferum. It is characterized by an exophytic proliferation of the epidermis
with two distinct keratinocytic structures: a) columns of hyperkeratotic mass surrounded by acanthotic epidermis
and b) papillated and/or cystic invaginations typical of syringocystoadenoma papilliferum. No causative agents were
reported.
Findings: The present report describes a typical case of apocrine acrosyringeal keratosis localized in the right
retro-auricular area of 57-year-old man in which the presence of HPV was evaluated. PCR analysis and direct
sequencing revealed the presence of HPV 89. The presence of this low risk mucosal HPV in a skin localization was
never reported as well as in association with this rare tumor. Furthermore rolling circle amplification, RT-PCR and
in situ hybridization confirmed the presence of a transcriptionally active HPV 89.
Conclusions: Taken together our results suggest that HPV89 plays a role in apocrine acrosyringeal keratosis with
syringocystoadenoma papilliferum, in consideration of the documented biological activity of the virus. The
association of low risk mucosal HPV infection with this skin lesion opens new perspectives in its clinical
management. Further studies on samples from other patients are needed to confirm this association.
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Human papillomaviruses (HPVs) can be considered
etiological agents of invasive cervical, anogenital, and
oropharyngeal, in particular tonsil, cancers [1, 2]. Cur-
rently, more than 180 HPV types have been fully
characterized; the majority clusters into 3 genera:
Alphapapillomavirus (alpha-HPV), mainly isolated
from genital lesions; Betapapillomavirus (beta-HPV)
and Gammapapillomavirus (gamma-HPV), the latter
two genera predominantly isolated from skin [3].
The tissue tropism of a group of viruses is an import-
ant characteristic to understand how viruses evolve in
ecological niches and induce pathogenic consequences
in their hosts. In line with this assumption persistent in-
fections by mucosal high-risk oncogenic alpha HPV
types such as HPV type 16 are associated with some oral
and/or oropharyngeal cancers [2, 4]. However, recent* Correspondence: venuti@ifo.it
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spectrum of known and novel HPV types that phylogen-
etically cluster into the beta- and gamma-HPV genera,
which were previously considered to be nearly exclu-
sively skin types [5]. The difference in the spectrum of
HPV types detected in the oral cavity and exfoliated cer-
vicovaginal cells has significant implications for our un-
derstanding of the anatomic tissue tropism, the
evolution of HPVs, and the epidemiological association
of HPV with oral and skin neoplasia.
On the contrary, mucosal types have been detected in
skin lesions and in particular HPV 16 was consistently
detected in periungueal carcinoma with Bowenoid fea-
tures [6]. Rare detection of other mucosal types has
been reported suggesting that HPV 16 is the only mu-
cosal type that possesses the ability not only to expand
into multiple human epithelial niches but also to cause
lesions in mucosal and cutaneous localizations [7].
This study was approved by the local Ethical Committee
(Prot.n. CE/312/05). A 57-year-old man was showing a le-
sion in the right retro-auricular area that was diagnosed asticle distributed under the terms of the Creative Commons Attribution License
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pathology was in the clinical history of the patient and in
particular no evidence of immunosuppression. The lesion
was exophytic and revealed two different components: a
well-developed syringocystoadenoma papilliferum (SCAP)
with free floating papillae and a more verrucous proliferativeFig. 1 (See legend on next page.)area resembling a wart (Fig. 1a,b,c). This wart-like area
showed acanthosis and papillomatosis of the epitelium
with focal trichilemmal keratinization; in some areas
the presence of hypergranulosis, columns of parakera-
tosis and perinuclear halo were suggestive of a possible
HPV infection (Fig. 1b high magnification inset).
(See figure on previous page.)
Fig. 1 Histological findings and HPV detection. a Apocrine acrosyringeal keratosis associated with syringocystoadenoma papilliferum. Higher
magnification of a warty-like area of apocrine acrosyringeal keratosis (b) and of a cystic area of syringocystoadenoma papilliferum (c). The arrow
in the inset indicates a cell with perinuclear halo suggestive of a possible HPV infection. d RCA. Genomic DNA extracted and purified from the
paraffin embedded sample was amplified with TempliPhi Amplification Kit (Amersham Biosciences, Milan, Italy) according to the manufacturer's
instruction except an higher (450 mM) concentration of nucleotides. To resolve the concatemers, RCA products were digested with BamHI,
(Invitrogen-Life Technologies, Monza, Italy), for 3 h at 37 °C in a total volume of 20 μl. Digestion products were resolved by 0.8 % agarose gel
electrophoresis. W12 is a cell line containing episomal HPV16. M is a Xlarge DNA Ladder (GeneDirex,Rome, Italy). The arrow indicates the amplified
band of about 8000 bp. e RT-PCR. Total RNA extracted and purified from the paraffin embedded sample was subjected to retro-transcription and
nested PCR with degenerate primers. Amplified products were resolved in ethidium bromide stained agarose gel. W12 is a cell line expressing
HPV16 mRNA. No RT is a control in which reverse transcriptase was omitted to exclude the presence of contaminating genomic DNA. M5 is a
DNA Molecular Weight Marker V (Roche, Milan, Italy). The arrow indicates the amplified products. f ISH: In situ hybridization was performed with
ZytoFast kit (Bioptica, Milan, Italy). Specific probes for HPV 89 were prepared by the asymmetric PCR [16] with consensus primers. The arrows
indicate cells with HPV positive green/blue stained nuclei. Since consecutive sections were not available, the corresponding localization in H/E
preparation cannot be displayed
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by different methods.
Sensitive PCR with degenerate primers followed by
direct sequencing was utilized to detect a broad spectrum
of HPV types [5, 8]. Rolling circle amplification (RCA), a
methodology that amplifies circular DNA [9], reverse
transcriptase (RT)-PCR followed by direct sequencing and
in situ hybridization (ISH) were also employed to define
physical status and mRNA transcription [10].
PCR analysis demonstrated the presence of an ampli-
fied band that upon direct sequencing revealed a nucleo-
tide sequence with 98 % homology to that of HPV 89
(Fig. 2). RCA showed a band of about 8000 bp after di-
gestion with single cutting BamHI restriction enzyme,
indicating the presence of episomal virus. This band was
higher than that of episomal HPV16 extracted from
W12 control cells because these two viruses are different
in genome length (Fig. 1d). To confirm that RCA prod-
uct was from HPV 89, RCA products were digested with
another single cutting enzyme (KpnI), amplified with CP
degenerate primers and subjected to direct sequencing
that confirmed the presence of HPV type 89.
HPV mRNA expression was detected by reverse tran-
scriptase–PCR (Fig. 1e). Total RNA was extracted from
dewaxed sections according to standard procedures that
allow the recovering of PCR-grade RNA [11, 12]. In
addition, the quality of RNA was preserved by maintain-
ing the biopsy in buffered formalin for a short period of
time. cDNA was retro-transcribed by a commercial kit
(Superscript Reverse Transcriptase, Life Technology,
USA). CP primers consisting of two sets of degenerate
primers located in the late L1 ORF were utilized to amp-
lify HPV sequences from cDNA [5, 8]. The annealing
sites of these primers have different positions in the gen-
ome of different HPV types. The CP65-CP70 primer set
and the nested CP66-CP69 primer set amplify products
ranging from 452- to 467-bp and from 374- to 389-bp,respectively. Indeed, the position of HPV89 amplified
band is slightly different from that of HPV16 form W12
cells (Fig. 1e). The amplified bands were excised from
the agarose gel and subjected to direct sequencing that
confirmed the presence of HPV89 L1 sequences.
Since no cloned HPV89 was available, viral load was
measured in real time-PCR respect to two different stand-
ard curves: SiHa cells with one integrated copy of HPV16
and a plasmid carrying HPV16 full genome (mimicking epi-
somal HPV). Briefly, real time PCR was performed with
Kapa SYBR Green Master Mix (KAPA-biosystems , Milan,
Italy) in i-Cycler apparatus (BioRad Laboratories Inc.,
Milan, Italy) according to manufacturer's instructions. Am-
plifications of L1 and β-globin gene were performed in a
20 μl volume containing 2× Kapa SYBR Fast qPCR Master
Mix, 10 μM of each primer and 20 ng of genomic DNA,
using the following protocol for 40 cycles: 3 s denaturation
at 95 °C, annealing and extension at 60 °C for 30 s, with the
initial denaturation at 95 °C for 3 min. Viral load was nor-
malized by β-globin gene and calculated as 0.73 copy/gen-
ome equivalent. Finally, ISH revealed a HPV positive
nuclear signal confirming data of RCA about the presence
of episomal HPV 89 (Fig. 1f).
In the present report, we bring evidence that tran-
scriptionally active low risk HPV 89 was present in apo-
crine acrosyringeal keratosis, a unique benign keratotic
lesion associated with syringocystoadenoma papilliferum
described on 2000 by Khishimoto et al. [13].
It is characterized by an exophytic proliferation of the
epidermis with two distinct keratinocytic structures: a)
columns of hyperkeratotic mass with swollen corneo-
cytes containing keratohyalin granules surrounded by
acanthotic epidermis and b) papillated and/or cystic in-
vaginations, typical of SCAP. This tumor is rarely ob-
served and, at the best of our knowledge, only one case
is reported in the English literature. Khishimoto et al.
made the hypothesis of HPV involvement but failed to
Fig. 2 HPV detection and typing. DNA from clinical sample was analysed for HPV detection by PCR with CP degenerate primers that amplify a
broad spectrum of HPVs. PCR conditions were 3 mM MgCl2, 200 μM dNTPs, 0.5 μM for each primer and 2.5 U of Platinum TaqDNA polymerase
(Life technologies, Milan, Italy) in a final reaction volume of 50 μl. Amplified products were sequenced in an automatic apparatus (Genechron
Biogen, Rome, Italy) and sequence analyses were performed using BLAST program (http://www.ncbi.nlm.nih.gov/BLAST). W12 is a cell line
containing episomal HPV16 utilized as positive control. M, molecular weight marker VIII (Roche, Milan, Italy)
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note that they utilized a low sensitive assay to identify
the presence of HPV.
On the contrary, Carlson and co-workers reported the
presence of alpha and beta HPV DNA in cases of syrin-
gocystadenoma papilliferum associated with nevus seba-
ceus, a complex hamartoma of the skin with epithelial
and dermal components, often associated with second-
ary neoplasms as trichoblastoma, basal cell carcinoma
and syringocystadenoma papilliferum [14].
The presence of this low risk mucosal HPV in a skin
localization was never reported as well as in associationwith this rare tumor. HPV 89 was recently associated
with a long duration of viral persistence in limited case
studies suggesting some peculiar characteristic of this
HPV [15]. Taken together our results suggest that
HPV89 plays a role in this rare pathology. In favor of
this hypothesis is the presence of episomal DNA and of
viral mRNA for L1 capsid protein (productive infection)
as well as a histology suggestive of HPV infection,
whereas against this hypothesis is the low copy number.
However, results from ISH may suggest that in few cells
the HPV89 is in high copy number compatible with viral
expression.
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ally active, may represent only a reactivation of latent in-
fection during the lesion development.
Nevertheless, the ascertained presence of mucosal
papillomavirus in skin locations reinforces the hypoth-
esis that a single type of HPV may have a different trop-
ism in comparison with other members of the same
species suggesting that genotyping classification may not
always reflect the biological behavior of the HPVs. The
role of symbiotic HPV infections, their relationship with
the host (e.g. commensal) and the emergence of their
pathogenic potential remain to be better understood.
In conclusion, apocrine acrosyringeal keratosis with
syringocystoadenoma papilliferum can be associated
with HPV infection. Although conclusive data cannot
extrapolated from a single case, nevertheless the possi-
bility of an association of this rare skin pathology with
an Alfa papillomavirus exists in consideration of the
documented activity of the virus. Further studies on
samples from other patients are needed to confirm this
association.
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Description of the work
The paper brings evidence that transcriptionally active low risk HPV 89, can
be revealed in apocrine acrosyringeal keratosis, a unique benign keratotic
lesion associated with syringocystoadenoma papilliferum. The ascertained
presence of an alpha low risk papillomavirus in skin locations reinforces the
hypothesis that a single type of HPV may have a different tropism in
comparison with other members of the same species suggesting that
genotyping classification may not always reflect the biological behavior of
the HPVs. The role of symbiotic HPV infections, their relationship with the
host and the emergence of their pathogenic potential remain to be better
understood.
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